ARTICLE | Deals
Launched by Mazumdar-Shaw, Parmar and Mukherjee, Immuneel takes step toward $50,000 CAR T for India
Bangalore biotech in-licenses therapy from Spain, targets clinic in 2021
October 13, 2020 8:16 PM UTC
Immuneel, a Bangalore start-up dedicated to making cancer cell therapies available in India at prices far below those charged in developed countries, announced Tuesday its first step to bring CAR T treatments to the subcontinent.
Immuneel Therapeutics Private Ltd. has licensed exclusive rights in India to ARI-0001, a CAR T that is being developed by Hospital Clínic de Barcelona (HCB) & August Pi i Sunyer Biomedical Research Institute (IDIBAPS). ...